MILLS KENNETH T. (President and CEO) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/3/2025ACC: 0001562180-25-004351
DirectorOfficer· President and CEO
Since Aug 2018
+47.58K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
47.58K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.77K
Price / share
—
Trade value
—
% of position
1.6%
5/30/2025
475.10K→482.87K
Total
Net shares
+7.77K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/30/2025 | A · Award | +7.77K | — | — | 1.6% | 475.10K | 482.87K |
| Total | +7.77K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
39.81K shares
Shares
+39.81K
Strike price
8.85
Held after
39.81K
Exercisable
—
5/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock39.81K shares | 5/30/2025 | A · Award | +39.81K | 8.85 | — | 39.81K |